Lataa...
Androgen receptor abnormalities in castration-recurrent prostate cancer
The androgen receptor (AR) plays a critical role in prostate cancer (PCa) development and progression. Despite the success of androgen-deprivation therapy, remission occurs in almost all cases. This stage of the disease is called castration-recurrent PCa (CRPC). CRPC cells adapt to low circulating l...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2835169/ https://ncbi.nlm.nih.gov/pubmed/20228873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/eem.09.34 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|